Fresia Pareja

42PUBLICATIONS
218CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTissue engineeringPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 10, 2026
CDKPredict: a clinicogenomic model for risk-adapted therapeutic intervention in breast cancer.

|Sep 09, 2026
ERBB2 Activating Mutations Promote Enhanced Internalization and Activity of Trastuzumab Deruxtecan in HER2-non-amplified Metastatic Breast Cancer.

|Jul 17, 2026
Microfluidic Tissue Array Platform for Personalized Drug Screening Using Tumor Explants or Biopsies.

|Jun 03, 2026
Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumours.

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.

Wanyi Chen, Avantika Gupta, Nicholas Mai

Pageof 7

Frequent Collaborators

23 joint publications

Jorge S Reis-Filho

17 joint publications

Britta Weigelt

14 joint publications

Edaise M da Silva

13 joint publications

Sarat Chandarlapaty